Biocept Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
Under the proposed rights offering,
The subscription rights are non-transferable and may only be exercised during the anticipated subscription period of
The expected calendar for the rights offering is as follows:
Thursday, July 19, 2018: Ownership Day — in order to be considered a stockholder of record on Monday, July 23, 2018, shares should be acquired by this date. Monday, July 23, 2018: Record Date Tuesday, July 24, 2018: Distribution Date; Subscription Period Begins Wednesday, August 8, 2018: Subscription Period Ends 5:00 PM ET(unless extended at Biocept'ssole discretion)
Holders who exercise their subscription rights in full will be entitled, if available, to subscribe for additional units that are not purchased by other stockholders, on a pro rata basis and subject to ownership limitations.
A registration statement relating to these securities has been filed with the
This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Cautionary Statement Regarding Forward-Looking Statements
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this release are not strictly historical, including without limitation statements as to our ability to improve the diagnosis and treatment of cancer, our ability to increase our commercial test volume and revenues, the commercial success of our partnership with
View original content with multimedia:http://www.prnewswire.com/news-releases/biocept-informs-stockholders-of-key-dates-and-terms-related-to-announced-rights-offering-300679205.html
Jody Cain, email@example.com, LHA Investor Relations, (310) 691-7100